These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacotherapy for systolic dysfunction: a review of randomized clinical trials. Gheorghiade M; Benatar D; Konstam MA; Stoukides CA; Bonow RO Am J Cardiol; 1997 Oct; 80(8B):14H-27H. PubMed ID: 9372994 [TBL] [Abstract][Full Text] [Related]
3. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers]. Kubota T; Takeshita A Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006 [TBL] [Abstract][Full Text] [Related]
4. The pharmacological treatment of heart failure: are we looking at the sunset of the neurohormonal hypothesis. Porcu M Ital Heart J; 2002 Jul; 3(7):437-8. PubMed ID: 12189976 [No Abstract] [Full Text] [Related]
5. Mechanistic and clinical rationales for using beta-blockers in heart failure. Bristow MR J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093 [TBL] [Abstract][Full Text] [Related]
6. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey. Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M; Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720 [TBL] [Abstract][Full Text] [Related]
7. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction. Weir R; McMurray JJ Heart; 2005 May; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602 [TBL] [Abstract][Full Text] [Related]
8. [Recent advances and limitations of medical treatment on heart failure]. Momomura S Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066 [TBL] [Abstract][Full Text] [Related]
9. Therapy modifications during hospitalization in patients with chronic heart failure. Detiček A; Locatelli I; Roblek T; Mrhar A; Lainscak M Eur J Intern Med; 2016 Apr; 29():52-8. PubMed ID: 26775137 [TBL] [Abstract][Full Text] [Related]
10. Evidence-based therapy for heart failure. Deedwania PC; Carbajal E Med Clin North Am; 2012 Sep; 96(5):915-31. PubMed ID: 22980055 [TBL] [Abstract][Full Text] [Related]
11. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons. Aronow WS J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528 [TBL] [Abstract][Full Text] [Related]
12. Treatment of heart failure with preserved systolic function. de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095 [TBL] [Abstract][Full Text] [Related]
13. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment. Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM; Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026 [TBL] [Abstract][Full Text] [Related]
14. Clinical trials of beta-blockers in heart failure: a class review. Yancy CW Am J Med; 2001 Apr; 110 Suppl 5A():7S-10S. PubMed ID: 11259751 [TBL] [Abstract][Full Text] [Related]
15. Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. Gheorghiade M; Albert NM; Curtis AB; Thomas Heywood J; McBride ML; Inge PJ; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW; Fonarow GC Congest Heart Fail; 2012; 18(1):9-17. PubMed ID: 22277172 [TBL] [Abstract][Full Text] [Related]
16. [Revised insights and therapeutic goals in the treatment of chronic heart failure]. van Veldhuisen DJ Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272 [TBL] [Abstract][Full Text] [Related]
17. [Chronic left heart failure. A focus on the pathogenetic basis of medical treatment]. Novosel MK; Haghfelt TH Ugeskr Laeger; 2006 May; 168(19):1854-6. PubMed ID: 16756801 [TBL] [Abstract][Full Text] [Related]
18. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879 [TBL] [Abstract][Full Text] [Related]
19. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162 [TBL] [Abstract][Full Text] [Related]
20. From left ventricular dysfunction to heart failure. Cleland JG Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]